Glucosamine Sulfate — strong evidence
Glucosamine Sulfate is the compound with the longest and most consistent clinical trial record in the joint supplement category. As the amino sugar precursor to glycosaminoglycans and proteoglycans — the structural molecules that form the cartilage matrix — it is biologically upstream of cartilage integrity. When cartilage is under stress or progressively wearing, providing the raw material for glycosaminoglycan synthesis gives the tissue what it needs to attempt structural maintenance.
The NIH-funded GAIT trial evaluated Glucosamine and Chondroitin across several thousand participants. The combination showed clinically significant responses in the subgroup with moderate to severe knee pain, and this finding has been replicated in multiple subsequent RCTs. The sulfate form — used in Joint Brex — is generally considered more bioavailable than glucosamine hydrochloride. Evidence grade: strong and consistent for structural joint support.
Chondroitin Sulfate — strong evidence
Chondroitin Sulfate works through a distinct but complementary mechanism to Glucosamine. As a highly hydrophilic (water-attracting) proteoglycan, it maintains the water content of cartilage — approximately 65 to 80 percent of healthy cartilage weight. This water retention is not incidental: it is the source of cartilage's hydraulic shock-absorbing properties. Without adequate Chondroitin, cartilage loses elasticity, compresses more easily and fails to spring back efficiently after loading.
Clinical trials consistently show that the Glucosamine + Chondroitin combination outperforms either ingredient individually for joint comfort outcomes, particularly in populations with established cartilage involvement. The synergy is not theoretical — it appears in the trial data. Evidence grade: strong, particularly in combination with Glucosamine.
Boswellia Extract — strong evidence
Boswellia serrata resin contains boswellic acids whose primary active form — AKBA (acetyl-keto-beta-boswellic acid) — specifically inhibits 5-lipoxygenase (5-LOX). The 5-LOX enzyme is the key step in leukotriene biosynthesis, and leukotrienes are the primary inflammatory molecules responsible for joint swelling, pain and tissue damage in chronic inflammatory joint conditions. By blocking 5-LOX rather than COX enzymes (the NSAID mechanism), Boswellia modulates inflammation through a pathway that NSAIDs leave unaddressed.
Multiple randomised controlled trials in knee osteoarthritis populations show statistically significant improvements in pain and physical function scores with standardised Boswellia extract versus placebo. Effect onset is typically 3 to 6 weeks of consistent daily dosing. Evidence grade: strong and mechanistically well-defined.
See all six Joint Brex ingredients with their individual amounts on the official site.
🧖 View Joint Brex FormulaTurmeric Curcumin — good and growing evidence
Turmeric curcumin is one of the most studied natural compounds across all biomedical disciplines. Its primary joint-relevant mechanism is NF-kB inhibition — NF-kB being the nuclear transcription factor that coordinates the inflammatory gene expression cascade in joint tissue. By modulating NF-kB signalling upstream, curcumin addresses a broader driver of chronic joint inflammation than Boswellia's 5-LOX pathway, making the two compounds genuinely complementary rather than redundant.
Published RCTs comparing curcumin to ibuprofen for knee osteoarthritis have shown comparable effects on pain scores with fewer gastrointestinal side effects. The main variable in curcumin research is bioavailability — native curcumin is poorly absorbed, and studies showing clinically meaningful effects typically use enhanced bioavailability formulations. Evidence grade: good and growing, with bioavailability formulation being the key quality differentiator.
MSM — solid rationale, moderate clinical data
Methylsulfonylmethane provides bioavailable organic sulfur — an essential element in the disulfide bonds of collagen and other structural proteins that form tendons, ligaments and the extracellular matrix surrounding cartilage. Sulfur is the third most abundant mineral in the human body, and collagen cannot maintain its mechanical integrity without it. MSM's structural contribution to the connective tissue environment surrounding joints is biologically well-supported.
Clinical trials on MSM specifically for joint pain show consistent, if modest, improvements in pain and function scores. Effect sizes are generally smaller than for Glucosamine or Boswellia, but MSM's role in the Joint Brex formula is as a structural support compound rather than a primary active. Its contribution is to the connective tissue environment — the tendons, ligaments and capsule — that the other ingredients do not directly address. Evidence grade: solid mechanistic rationale, moderate and consistent clinical data for joint applications.
Bromelain — good mechanistic evidence
Bromelain is a proteolytic (protein-digesting) enzyme complex extracted from pineapple stem. Its documented mechanisms include fibrinolysis (breaking down fibrin deposits that accumulate in inflamed and injured tissue) and modulation of pro-inflammatory cytokines. By clearing fibrin from the peri-articular environment, Bromelain improves local blood flow to the joint space — which is particularly relevant given that cartilage itself has no direct blood supply and depends on synovial fluid circulation for nutrient delivery.
The clinical evidence for Bromelain in post-surgical recovery and acute inflammation is strong. For chronic joint pain specifically, the trial base is more limited than for the structural ingredients, but the mechanistic rationale for its inclusion — supporting circulation and recovery in the joint space — is sound and distinct from what the other five compounds contribute. Evidence grade: good mechanistic evidence, more limited but consistent data for chronic joint applications specifically.
Keep reading
More articles on the Joint Brex blog. Visit the Joint Brex official site for pricing.
Glucosamine Sulfate + Chondroitin Sulfate in combination have the most extensive evidence — subject of the NIH GAIT trial and multiple large RCTs. Boswellia also has strong, consistent evidence through 5-LOX inhibition.
No. All six ingredients are listed with individual amounts — no proprietary blend. This allows direct comparison of each dose against the clinical research.
For healthy adults without shellfish allergy or anticoagulant medication, generally well-tolerated. Key risks: Glucosamine contains shellfish allergen; Bromelain and Turmeric interact with blood thinners. Consult your physician before use.
